John G. Ullman & Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Buy |
16,100
+1,150
| +8% | +$31.7K | 0.07% | 127 |
|
|
2025
Q1 | $424K | Buy |
14,950
+4,650
| +45% | +$132K | 0.07% | 135 |
|
|
2024
Q4 | $428K | Sell |
10,300
-39,350
| -79% | -$1.64M | 0.06% | 134 |
|
|
2024
Q3 | $3.32M | Buy |
49,650
+38,400
| +341% | +$2.57M | 0.48% | 69 |
|
|
2024
Q2 | $1.34M | Sell |
11,250
-150
| -1% | -$17.8K | 0.2% | 94 |
|
|
2024
Q1 | $1.21M | Buy |
11,400
+7,750
| +212% | +$826K | 0.19% | 91 |
|
|
2023
Q4 | $363K | Sell |
3,650
-37,949
| -91% | -$3.77M | 0.06% | 135 |
|
|
2023
Q3 | $4.3M | Buy |
41,599
+13,200
| +46% | +$1.36M | 0.7% | 43 |
|
|
2023
Q2 | $3.45M | Buy |
+28,399
| New | +$3.45M | 0.53% | 54 |
|